Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

iShares U.S. Medical Devices ETF (NY: IHI )

59.02 +0.44 (+0.76%)
Streaming Delayed Price Updated: 1:46 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about iShares U.S. Medical Devices ETF

< Previous 1 2 Next >
Biotech Rally Coming In Weeks Ahead?
Large cap biopharma and MedTech stocks are leading the healthcare sector higher. 
Via Talk Markets
Topics ETFs Stocks / Equities
Trading OGRes And IPOs - The Week In Charts
A discussion about recent OGRe trades and a Buy At B IPO trade. 
Via Talk Markets
Topics ETFs Initial Public Offering Stocks / Equities
Exposures Securities Market
Biotech Stocks Stay Strong Through A Period Of Uncertainty In The Market
Many analysts are feeling better about the prospects for healthcare stocks in 2025. 
Via Talk Markets
Topics ETFs Stocks / Equities
NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst
Robert F. Kennedy Jr.'s appointment as Secretary of Health and Human Services has sparked concerns over funding for the NIH. 
Via Benzinga
Can Biotech Stocks Survive The Precarious Macro?
We were having a nice rally in January 2025 until the reality of tariffs hit on Friday which killed the momentum developing off the mid-January lows. 
Via Talk Markets
Topics Stocks / Equities World Trade
Exposures Tariff
DeepSeek Shakes Up AI Stocks: 3 Healthcare Tech ETFs Offer Stability, Innovation
DeepSeek's AI model causes tech stocks to drop, but healthcare tech ETFs benefit from advancements in AI without vulnerability to market volatility. 
Via Benzinga
Topics Artificial Intelligence ETFs
Exposures Artificial Intelligence
Biotech And Healthcare Stocks Poised For Gains Ahead
The XLV bounced off the bottom this month up 4% to the $144 level led by biopharma and medtech. 
Via Talk Markets
Topics ETFs Stocks / Equities
Healthcare And Biotech Stocks Lag The Market Again
Biotech stocks got little help from the JPM Conference despite some recovery to the general market. 
Via Talk Markets
Topics Stocks / Equities
Intuitive Surgical Stock Hits All-Time High After Prelim Q4 Results Outpace Expectations: Retail Goes All In
Intuitive said worldwide da Vinci procedure volumes grew 18% in Q4 and 17% in 2024, driven by U.S. general surgery and international cancer procedures. 
Via Stocktwits
It’s Been A Tough Month For Healthcare Stocks
It’s been a very difficult month for the healthcare sector not only because of disappointing company news but also disruption caused by the election and future policy issues. 
Via Talk Markets
Topics ETFs Stocks / Equities
What Does the Economic Modern Family Say Now?
Considering where the Economic Modern Family was just a few weeks ago, clearly euphoria has spread since the election. 
Via Talk Markets
Healthcare Sector Update: Choppy Days Are Here Again As Yields Rise
There has been a shift in healthcare stock performance by sub-sector which should be confirmed as we move through the Q3 earnings cycle. 
Via Talk Markets
Can You Lose Money Investing in ETFs? 3 Things to Know.
ETFs can be safe yet powerful investments. But there are still risks involved. 
Via The Motley Fool
Topics ETFs
Stryker Unveils New Foot & Ankle Solutions With Truss Implants: Details
Stryker Corporation announced new Foot & Ankle products from 4WEB Medical, with analysts maintaining positive ratings. 
Via Benzinga
CME Group, Chubb, Berkshire Hathaway And More On CNBC's 'Final Trades'
Kevin Simpson of Capital Wealth Planning said CME Group yields a 4.5% dividend and trades at a forward PE of 21, which is pretty low. 
Via Benzinga
ETF Winners Of Q2 Earnings: 4 Must-See Charts
This article lists four ETFs from different sectors that have gained from strong earnings despite the market volatility. 
Via Talk Markets
Topics ETFs
Large Cap Biopharma And Healthcare, A Port In A Storm
Healthcare and biopharma show nice gains in a volatile week. 
Via Talk Markets
Want to Earn More in the Stock Market With Less Effort? Try This Simple Strategy
You don't need to be a stock market expert to earn above-average returns. 
Via The Motley Fool
The All-Weather ETF Trifecta: 3 Funds to Buy and Hold Forever
These long-term ETfs to buy and hold offer exposure to the best-performing market segments with improved diversification to boot. 
Via InvestorPlace
Topics ETFs
The 3 Best ETFs to Buy in May 2024
The best ETFs to buy in May capture sectors on sale and help build a well-rounded, diversified portfolio for long-term investors. 
Via InvestorPlace
Topics ETFs
April Showers On Wall Street: Miners, Utilities Emerge As Bright Spots In Gloomy Market
Performance in April 2024: Utilities lead, real estate lags. S&P 500, Nasdaq 100, Dow Jones Industrial Average, small-cap and large-cap indices all decline. 
Via Benzinga
Topics Stocks
Exposures US Equities
3 ETFs That Could Turn Your Portfolio Into a Tech Powerhouse
Staking your tech holdings on a few mega-caps isn't the wisest move; instead, diversify your holdings across these top tech ETFs. 
Via InvestorPlace
Topics ETFs
Healthcare Stocks Are Looking Better But What About Biotech?
Large cap biopharmacuiticals remain a core holding for growth and value despite political cross-currents on drug pricing. 
Via Talk Markets
Biotech And Medtech Portfolio Notes On A Fed Day
The Fed held rates keeping their future options flexible with no expectations for future cuts. The market did not like it and sold off with the Russell 2000 down 2.45% and the NASDAQ down 2.23% 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Momentum Shifts Back To Tech Stocks As Healthcare Lags In 2024
Small Cap traders are taking a break in 2024 as XBI is down 2.51% YTD. 
Via Talk Markets
3 Thematic Growth ETFs to Load Up on Right Now
These three thematic ETFs could be potent growth vehicles in years to come. 
Via The Motley Fool
Topics ETFs
Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?
Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story. 
Via Investor's Business Daily
Pivotal Week Coming Up: Big Tech Earnings, Geopolitics, Technicals, Treasury Yield...
The upcoming quarter GDP is expected to hit 3.7% which has brought the FED dialogue to “higher rates for longer” which might lead us to a recession in 2024. So watch the yield on the 10-year TSY now at... 
Via Talk Markets
Topics Economy
Exposures Economy
Elon Musk-Owned Neuralink's Brain Implant Could Fetch Over $220M Revenue In ALS Patients By 2030, Says Ark Analyst
Neuralink's N1 implant is cosmetically invisible and is intended to record and transmit brain signals wirelessly to an app that decodes movement intention. 
Via Benzinga
Amid Israel-Palestine And Ukraine Gas, Gold Up Big, Cathie Wood's ARKK Down Almost 4% - ETF Winners And Losers: Medium-Cap Returns
Via Benzinga
Topics ETFs
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.